Diabetic kidney disease research: Where do we stand at the turn of the century?

Kidney International, Supplement

Volumn 58, Issue 77, 2000, Pages

  Lee, H B ^a   Ha, H ^a   Kim, S I ^a   Ziyadeh, F N ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALDEHYDE REDUCTASE; ANGIOTENSIN; GLUTAMINE FRUCTOSE 6 PHOSPHATE AMINOTRANSFERASE; HEXOSAMINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; MEVINOLIN; REACTIVE OXYGEN METABOLITE; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

CELL CYCLE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; EDITORIAL; EXTRACELLULAR MATRIX; HUMAN; MESANGIUM CELL; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; SIGNAL TRANSDUCTION; ANIMAL; ARTICLE;

ANIMALS; DIABETIC NEPHROPATHIES; HUMANS;

EID: 0033852454     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.07701.x     Document Type: Editorial

References (0)